Skip to content

Effects of Six Months of Moderate Resistance- Versus Endurance-Training on Muscle ATP Synthesis in First-Degree Relatives of Patients With Type 2 Diabetes

Effects of Six Months of Moderate Resistance- Versus Endurance-Training on Muscle ATP Synthesis in First-Degree Relatives of Patients With Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01145092
Acronym
RECO2
Enrollment
16
Registered
2010-06-16
Start date
2006-02-28
Completion date
2009-03-31
Last updated
2010-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Type 2 Diabetes Mellitus

Keywords

type 2 diabetes, exercise training, ATP-synthesis, intramyocellular lipids, hepatocellular lipids, first degree relatives of T2DM patients

Brief summary

Life style intervention including diet and exercise is the recommended strategy for prevention of type 2 diabetes mellitus (T2DM). First-degree relatives of patients with type 2 diabetes mellitus have an increased risk of insulin resistance and a lifetime risk of developing type 2 diabetes of 40%- 80%. Poor physical fitness is a strong indicator of an increased risk of developing diabetes. Long-term endurance exercise training has been shown to increase insulin sensitivity in sedentary young and elderly individuals, first degree relatives of patients with Type 2 diabetes, glucose intolerant obese, or Type 2 diabetic humans. In type 2 diabetic patients, non-diabetic individuals with IGT and sedentary adults after exercise training of different intensity, different duration and different frequency an increase of insulin sensitivity was found. However, despite the vast knowledge concerning beneficial effects physical activity for the prevention of T2DM (and many other chronic metabolic disorders) to date wide ranging strategies have not been realized satisfactory. Regardless of age, ethnicity, sex or health status the lack of time is the primary reason for the failure to exercise on a regular basis (or is stated as primary reason). Therefore the investigators aimed at investigating whether a controlled endurance/resistance training twice a week over 6 month might be beneficial for healthy, non obese, first degree relatives with T2DM. Therefore the investigators measure parameters associated with the prevention of T2DM like insulin sensitivity, flux through fATPase and fCK, intramyocellular and hepatocellular lipids.

Interventions

BEHAVIORALexercise training, endurance training

The endurance training group exercised on a cycle ergometer (90% of power output determined at the respiratory compensation point = RCP). The duration of each training unit was increased with time. The resistance group trained on 8 weight machines where the workload gradually increased every 2-3 weeks. At week 13 an additional physical examination, OGTT and spiro-ergometry for adjusting the training were performed.

Sponsors

Mein Hanusch-Krankenhaus
CollaboratorOTHER
Karl-Landsteiner Institute for Endocrinology and Metabolism
CollaboratorUNKNOWN
Medical University of Vienna
CollaboratorOTHER
Lund University
CollaboratorOTHER
Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy
CollaboratorOTHER_GOV
Landsteiner Institut
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* First degree relatives of type 2 diabetic patients * Age: 18-50 years * BMI \<30 kg/m2 (due to limited MR diameter) * Normal routine lab tests (blood cell count, kidney, liver, pancreas, thyroid and neuromuscular function) * Availability within the local area throughout the study * Ability to understand and sign the consent forms

Exclusion criteria

* Current smoking * Present drug treatment * Regular exercise training * Contraindications for MRS studies: claustrophobia and metalliferous implants * Pregnancy * HIV or Hepatitis * Acute disease 2 weeks previous to the examination * Heart disease * Hypertension (RR\>140/95) * Liver disease * Kidney disease * Pulmonary disease * Thyroid disease

Design outcomes

Primary

MeasureTime frameDescription
Insulin Sensitivitymeasured by oral glucose tolerance test

Secondary

MeasureTime frameDescription
incremental test power, oxygen uptake (VO2 in ml.kg-1.min-1), aerobic threshold (RCP= respiratory compensation point)This test was performed on an electronically braked cycle ergometer
ATP-Synthesismeasured with 13C NMR
liver lipid contentmeasured with 1H NMR
skeletal muscle lipid contentmeasured by 1H NMR

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026